SONIDEGIB 200MG NVR Pill - pink capsule/oblong
Generic Name: sonidegib
Pill with imprint SONIDEGIB 200MG NVR is Pink, Capsule/Oblong and has been identified as Odomzo 200 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Odomzo is used in the treatment of Basal Cell Carcinoma and belongs to the drug class hedgehog pathway inhibitors. Odomzo 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SONIDEGIB 200MG NVR
Odomzo
- Generic Name
- sonidegib
- Imprint
- SONIDEGIB 200MG NVR
- Strength
- 200 mg
- Color
- Pink
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Hedgehog pathway inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0645 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
lactose monohydrate,
magnesium stearate,
poloxamer 188,
sodium lauryl sulfate,
gelatin,
ferric oxide red,
titanium dioxide,
ammonia,
ferrosoferric oxide,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
More about Odomzo (sonidegib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: hedgehog pathway inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
